Trial Profile
Pivotal study of P128 in patients with Staphylococcus aureus infection
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jul 2016
Price :
$35
*
At a glance
- Drugs P 128-GangaGen (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- 15 Jul 2016 New trial record